351
Views
4
CrossRef citations to date
0
Altmetric
Clinical Study

Comparison of two levonorgestrel-releasing intrauterine systems for the treatment of heavy menstrual bleeding: a randomised, controlled, phase 3 trial

, , , , , , & show all
Pages 491-498 | Received 06 Jan 2021, Accepted 08 Jun 2021, Published online: 28 Jun 2021

References

  • Sriprasert I, Pakrashi T, Kimble T, et al. Heavy menstrual bleeding diagnosis and medical management. Contracept Reprod Med. 2017;2:20.
  • Lethaby A, Wise MR, Weterings MA, et al. Combined hormonal contraceptives for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019;2(2):CD000154.
  • Karlsson TS, Marions LB, Edlund MG. Heavy menstrual bleeding significantly affects quality of life. Acta Obstet Gynecol Scand. 2014;93(1):52–57.
  • Bitzer J, Serrani M, Lahav A. Women’s attitudes towards heavy menstrual bleeding, and their impact on quality of life. Open Access J Contracept. 2013;4:21–28.
  • National Institute for Health and Care Excellence (NICE). Heavy menstrual bleeding: assessment and management. NICE guideline (NG88). UK: NICE; 2018. [updated 2020 Mar 31]. Available from: https://www.nice.org.uk/guidance/ng88/resources/heavy-menstrual-bleeding-assessment-and-management-pdf-1837701412549 and https://www.nice.org.uk/guidance/ng88
  • Mawet M, Nollevaux F, Nizet D, et al. Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a one-year randomised controlled trial . Eur J Contracept Reprod Health Care. 2014;19(3):169–179.
  • Critchley HO, Maybin JA, Armstrong GM, et al. Physiology of the endometrium and regulation of menstruation. Physiol Rev. 2020;100(3):1149–1179.
  • Levosert 20 micrograms/24 hours intrauterine delivery system. Summary of product characteristics: Gedeon Richter (UK) Ltd; 2019. [updated 29 August 2019]. Available from: https://www.medicines.org.uk/emc/product/1789/smpc
  • Mirena 20 micrograms/24 hours intrauterine delivery system. Summary of product characteristics: Bayer plc; 2020 [updated 19 May 2020]. Available from: https://www.medicines.org.uk/emc/product/1132.
  • Lyseng-Williamson KA. Levonorgestrel 52 mg intrauterine system (Levosert®)/Liletta®) in contraception: a profile of its use. Drugs Ther Perspect. 2020;36(12):539–546.
  • Westhoff CL, Keder LM, Gangestad A, et al. Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system. Contraception. 2020;101(3):159–161.
  • Warner PE, Critchley HO, Lumsden MA, et al. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. Am J Obstet Gynecol. 2004;190(5):1216–1223.
  • Wyatt KM, Dimmock PW, Walker TJ, et al. Determination of total menstrual blood loss. Fertil Steril. 2001;76(1):125–131.
  • Munro MG, Critchley HO, Fraser IS, et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143(3):393–408.
  • Laster LL, Johnson MF. Non-inferiority trials: the ‘at least as good as’ criterion. Statist Med. 2002;22(2):187–200.
  • Chen BA, Eisenberg DL, Schreiber CA, et al. Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding. Am J Obstet Gynecol. 2020;222(4S):S888.e1–S888.e6.
  • Percy L, Mansour D, Fraser I. Iron deficiency and iron deficiency anaemia in women. Best Pract Res Clin Obstet Gynaecol. 2017;40:55–67.
  • Kocaoz S, Cirpan R, Degirmencioglu AZ. The prevalence and impacts heavy menstrual bleeding on anemia, fatigue and quality of life in women of reproductive age. Pak J Med Sci. 2019;35(2):365–370.
  • Mansour D, Hofmann A, Gemzell-Danielsson K. A review of clinical guidelines on the management of iron deficiency and iron-deficiency anemia in women with heavy menstrual bleeding. Adv Ther. 2021;38(1):201–225.
  • Fraser IS, Mansour D, Breymann C, et al. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Int J Gynaecol Obstet. 2015;128(3):196–200.
  • Peuranpää P, Heliövaara-Peippo S, Fraser I, et al. Effects of anemia and iron deficiency on quality of life in women with heavy menstrual bleeding. Acta Obstet Gynecol Scand. 2014;93(7):654–660.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.